Hyaluronate-based solutions for diverse industries
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of the original patent to develop novel applications of hyaluronate compositions in wastewater treatment, agriculture, wound healing, 3D bioprinting, and arthritis treatment.
Background and Problem Solved
The original patent disclosed a method for making modified hyaluronate compositions for soft tissue fillers. However, the patent's scope was limited to the medical field. This inventive concept addresses the need for innovative solutions in various industries by applying the core technology to new applications, thereby expanding the reach and impact of the original patent.
Detailed Description of the Inventive Concept
The new claims encompass a range of applications, including a system for treating wastewater using hyaluronate compositions for flocculation and clarification, a method for improving crop yields with hyaluronate-based soil amendments, a device for wound healing featuring hyaluronate gel dressings, a system for 3D bioprinting using hyaluronate-based bioinks, and a method for treating arthritis with hyaluronate compositions. Each application leverages the unique properties of hyaluronate, such as its ability to control swelling, enhance hydration, and promote tissue repair.
Novelty and Inventive Step
The new claims introduce novel and non-obvious applications of hyaluronate compositions, expanding beyond the original patent's scope in soft tissue fillers. The inventive step lies in recognizing the potential of hyaluronate in diverse industries and adapting the core technology to address specific problems in these fields.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using different salt concentrations, varying the molecular weight distribution of the hyaluronate, or incorporating additional components to enhance the performance of the compositions in each application.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including wastewater treatment, agriculture, medical devices, 3D bioprinting, and pharmaceuticals. The target market includes companies and organizations seeking innovative solutions to specific problems in these fields.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/1652 |
| A | A61 | A61K8/735 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K9/06 |
| A | A61 | A61K9/1658 |
| A | A61 | A61K31/167 |
| A | A61 | A61K47/42 |
| A | A61 | A61Q19/08 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomaterials and pharmaceutical compositions, specifically hyaluronic acid-based formulations for medical and industrial applications, requiring advanced knowledge of polymer chemistry, biotechnology, and materials engineering
Person of Ordinary Skill (PHOSITA) Profile
A researcher or engineer with a PhD or equivalent experience in biomaterials science, with expertise in polymer modification, crosslinking techniques, and understanding of hyaluronic acid's physicochemical properties across multiple application domains
Obviousness Rationale
A PHOSITA would recognize that the fundamental properties of hyaluronic acid disclosed in the source patent enable multiple industrial and medical applications through predictable modifications of salt concentration, crosslinking ratio, and particle size. The variations in the PTD represent straightforward extensions of known hyaluronate composition techniques to solve specific technical challenges in different fields. The core technological principles remain consistent across the proposed applications, making the adaptations obvious to a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,682 |
|---|---|
| Title | Hyaluronate compositions and soft tissue fillers |
| Assignee(s) | AMC |